Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Rhino-orbital mucormycosis during steroid therapy in COVID-19 patients: A case report
Amirreza Veisi, Abbas Bagheri, M Eshaghi, et al.
European Journal of Ophthalmology (2021) Vol. 32, Iss. 4, pp. NP11-NP16
Open Access | Times Cited: 143

Showing 1-25 of 143 citing articles:

Mucormycosis in COVID-19: A systematic review of cases reported worldwide and in India
Awadhesh Kumar Singh, Ritu Singh, Shashank Joshi, et al.
Diabetes & Metabolic Syndrome Clinical Research & Reviews (2021) Vol. 15, Iss. 4, pp. 102146-102146
Open Access | Times Cited: 992
The emergence of COVID-19 associated mucormycosis: a review of cases from 18 countries
Martin Hoenigl, Danila Seidel, Agostinho Carvalho, et al.
The Lancet Microbe (2022) Vol. 3, Iss. 7, pp. e543-e552
Open Access | Times Cited: 387
COVID‐19‐associated mucormycosis: An updated systematic review of literature
Rimesh Pal, Birgurman Singh, Sanjay Kumar Bhadada, et al.
Mycoses (2021) Vol. 64, Iss. 12, pp. 1452-1459
Open Access | Times Cited: 244
Epidemiology and Pathophysiology of COVID-19-Associated Mucormycosis: India Versus the Rest of the World
Valliappan Muthu, Shivaprakash M. Rudramurthy, Arunaloke Chakrabarti, et al.
Mycopathologia (2021) Vol. 186, Iss. 6, pp. 739-754
Open Access | Times Cited: 201
Mucormycosis: An opportunistic pathogen during COVID-19
Mahalaxmi Iyer, Kaavya Jayaramayya, Dhivya Venkatesan, et al.
Environmental Research (2021) Vol. 201, pp. 111643-111643
Open Access | Times Cited: 179
Mucormycosis and COVID‐19: An epidemic within a pandemic in India
Lav Selarka, Suktara Sharma, Dinesh Kumar Saini, et al.
Mycoses (2021) Vol. 64, Iss. 10, pp. 1253-1260
Open Access | Times Cited: 164
COVID-19 and mucormycosis superinfection: the perfect storm
Jaffar A. Al‐Tawfiq, Saad Alhumaid, Abeer N. Alshukairi, et al.
Infection (2021) Vol. 49, Iss. 5, pp. 833-853
Open Access | Times Cited: 156
Mucormycosis in patients with COVID‐19: A cross‐sectional descriptive multicentre study from Iran
Farzad Pakdel, Kazem Ahmadikia, Mohammadreza Salehi, et al.
Mycoses (2021) Vol. 64, Iss. 10, pp. 1238-1252
Open Access | Times Cited: 149
COVID-19-associated mucormycosis: Case report and systematic review
Ahmet Dilek, Reşat Özaras, Şevket Özkaya, et al.
Travel Medicine and Infectious Disease (2021) Vol. 44, pp. 102148-102148
Open Access | Times Cited: 85
Invasive Fungal Infections Complicating COVID-19: A Narrative Review
Giacomo Casalini, Andrea Giacomelli, Annalisa Ridolfo, et al.
Journal of Fungi (2021) Vol. 7, Iss. 11, pp. 921-921
Open Access | Times Cited: 82
Overview on the Prevalence of Fungal Infections, Immune Response, and Microbiome Role in COVID-19 Patients
Maryam Roudbary, Sunil Kumar, Awanish Kumar, et al.
Journal of Fungi (2021) Vol. 7, Iss. 9, pp. 720-720
Open Access | Times Cited: 81
Mucormycosis: risk factors, diagnosis, treatments, and challenges during COVID-19 pandemic
Ayushi Sharma, Anjana Goel
Folia Microbiologica (2022) Vol. 67, Iss. 3, pp. 363-387
Open Access | Times Cited: 62
Mucormycosis and COVID-19 pandemic: Clinical and diagnostic approach
Asim Azhar, Wajihul Hasan Khan, Parvez Anwar Khan, et al.
Journal of Infection and Public Health (2022) Vol. 15, Iss. 4, pp. 466-479
Open Access | Times Cited: 40
Fungal Infection in Co-infected Patients With COVID-19: An Overview of Case Reports/Case Series and Systematic Review
Sima Sadat Seyedjavadi, Parmida Bagheri, Mohammad Javad Nasiri, et al.
Frontiers in Microbiology (2022) Vol. 13
Open Access | Times Cited: 39
Surge of mucormycosis during the COVID-19 pandemic
Paulami Dam, Marlon H. Cardoso, Sukhendu Mandal, et al.
Travel Medicine and Infectious Disease (2023) Vol. 52, pp. 102557-102557
Open Access | Times Cited: 29
COVID-19 associated mucormycosis: the urgent need to reconsider the indiscriminate use of immunosuppressive drugs
Alfonso J. Rodríguez‐Morales, Ranjit Sah, José Oñate, et al.
Therapeutic Advances in Infectious Disease (2021) Vol. 8
Open Access | Times Cited: 50
COVID-19 Associated Mucormycosis: A Systematic Review from Diagnostic Challenges to Management
Farah Yasmin, Hala Najeeb, Aisha Naeem, et al.
Diseases (2021) Vol. 9, Iss. 4, pp. 65-65
Open Access | Times Cited: 49
COVID-19-Associated Mucormycosis (CAM): Case-Series and Global Analysis of Mortality Risk Factors
Abanoub Riad, Alshaimaa Ahmed Shabaan, Julien Issa, et al.
Journal of Fungi (2021) Vol. 7, Iss. 10, pp. 837-837
Open Access | Times Cited: 42
Mucormycosis in COVID-19: A systematic review of literature
Shivaraj Nagalli, Nidhi Shankar Kikkeri
Infezioni in Medicina (2021) Vol. 29, Iss. 4
Open Access | Times Cited: 42
Mucormycosis (black fungus) ensuing COVID-19 and comorbidity meets - Magnifying global pandemic grieve and catastrophe begins
Karthika Pushparaj, Haripriya Kuchi Bhotla, Vijaya Anand Arumugam, et al.
The Science of The Total Environment (2021) Vol. 805, pp. 150355-150355
Open Access | Times Cited: 41
COVID-19-Associated Mucormycosis (CAM): An Updated Evidence Mapping
Salman Hussain, Harveen Baxi, Abanoub Riad, et al.
International Journal of Environmental Research and Public Health (2021) Vol. 18, Iss. 19, pp. 10340-10340
Open Access | Times Cited: 41
Retracted: Mucormycosis infection in patients with COVID‐19: A systematic review
SeyedAhmad SeyedAlinaghi, Amirali Karimi, Alireza Barzegary, et al.
Health Science Reports (2022) Vol. 5, Iss. 2
Open Access | Times Cited: 35
COVID-19 associated mucormycosis – An emerging threat
Chien‐Ming Chao, Chih‐Cheng Lai, Wen‐Liang Yu
Journal of Microbiology Immunology and Infection (2022) Vol. 55, Iss. 2, pp. 183-190
Open Access | Times Cited: 31
Current Treatment Options for COVID-19 Associated Mucormycosis: Present Status and Future Perspectives
Madhavan Yasasve, Kadambari Vijay Sai, Dilip Kumar Shanmugam, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 13, pp. 3620-3620
Open Access | Times Cited: 28
Coronavirus Disease-Associated Mucormycosis from a Tertiary Care Hospital in India: A Case Series
Yudhyavir Singh, Venkata Ganesh, Shailendra Kumar, et al.
Cureus (2021)
Open Access | Times Cited: 39
Page 1 - Next Page

Scroll to top